EOS, Tecomet, Precision ADM and OIC partner to provide end-to-end medical device Additive Manufacturing
EOS, headquartered in Krailling, Germany, along with Tecomet, Inc., Woburn, Massachusetts, USA, Orthopaedic Innovation Centre (OIC) and Precision ADM, both based in Winnipeg, Manitoba, Canada, have announced a collaborative partnership offering an end-to-end solution for medical device Additive Manufacturing. The partnership reportedly includes a full range of services including front-end engineering and design services, 510k approval pathways, device and machine validation, pre-clinical testing, and commercialisation.
This new partnership seeks to offer a complete end-to-end solution to customers starting from product design and process development, to large-scale manufacturing and as well as testing, validation and FDA submission. The advantage for medical OEMs is seen as a significant reduction in product development lead-time and a reduced time to market and overall risk, while leveraging the most recent manufacturing innovations.
This collaboration looks to harness the strengths and industry knowledge of each organisation. EOS, for example, specialises in both metal and polymer AM, whereas Tecomet focuses on the precision manufacturing of medical devices and components. OIC provides accredited medical device testing and contract clinical research services to the orthopaedic industry and Precision ADM provides comprehensive engineering and AM contract services to the medical device industry. This cohesive team works to enable medical device manufacturers to compress their time-to-market.
